(Q28592011)

31 January 2017

title

Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages (English)

1 reference

31 January 2017

0 references

0 references

1 reference

1 reference

GOA release 2020-03-11

author name string

Hideki Kitaura

1

1 reference

31 January 2017

Noriko Nagata

2

1 reference

31 January 2017

Yuji Fujimura

3

1 reference

31 January 2017

Hitoshi Hotokezaka

4

1 reference

31 January 2017

Mutsuhito Tatamiya

5

1 reference

31 January 2017

Noriko Nakao

6

1 reference

31 January 2017

Noriaki Yoshida

7

1 reference

31 January 2017

Koji Nakayama

8

1 reference

31 January 2017

publication date

8 September 2003

1 reference

31 January 2017

1 reference

31 January 2017

volume

88

1 reference

31 January 2017

issue

3

1 reference

31 January 2017

page(s)

193–198

1 reference

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Tumor necrosis factor-alpha mediates orthopedic implant osteolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Effects of interleukin-4 on the formation of macrophages and osteoclast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas/Fas ligand interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Short-term treatment of recombinant murine interleukin-4 rapidly inhibits bone formation in normal and ovariectomized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Osteoporosis induced in mice by overproduction of interleukin 4.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Interleukin-4 as a potent inhibitor of bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

Interleukin 4 inhibits murine osteoclast formation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2803%2900082-8

7 January 2021

10.1016/S0165-2478(03)00082-8

Identifiers

DOI

0 references

1 reference